These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


586 related items for PubMed ID: 7511753

  • 1. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
    van Wijngaarden J, Smit AJ, de Graeff PA, van Gilst WH, van der Broek SA, van Veldhuisen DJ, Lie KI, Wesseling H.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
    [Abstract] [Full Text] [Related]

  • 2. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S.
    Curr Med Res Opin; 2001 Oct; 17(4):290-7. PubMed ID: 11922403
    [Abstract] [Full Text] [Related]

  • 5. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M, Lauri G, Melzi G, Cattadori G, Agostoni P.
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [Abstract] [Full Text] [Related]

  • 6. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

  • 7. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [Abstract] [Full Text] [Related]

  • 8. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Jun; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 9. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
    Dékány M, Bányai F, Antalóczy Z.
    Acta Physiol Hung; 1988 Jun; 72 Suppl():93-110. PubMed ID: 3075406
    [Abstract] [Full Text] [Related]

  • 10. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [Abstract] [Full Text] [Related]

  • 11. [Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
    Figulla HR, Luig H, Nieschlag F, Kreuzer H.
    Z Kardiol; 1987 Mar; 76(3):167-74. PubMed ID: 3109142
    [Abstract] [Full Text] [Related]

  • 12. Acute renal effects of captopril in patients with congestive heart failure.
    Ribstein J, Mimran A.
    J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554
    [Abstract] [Full Text] [Related]

  • 13. Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
    MacIntrye IM, Jhund PS, McMurray JJ.
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):261-5. PubMed ID: 16187007
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
    Ferreira SR, Saragoça MA, Homsi E, Ajzen H, Draibe SA, Ribeiro AB, Ramos OL.
    J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
    [Abstract] [Full Text] [Related]

  • 15. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989 Dec; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 16. [Hemodynamic and clinical effects of captopril in congestive heart failure].
    Galiè N, Magelli C, Ribani MA, Bassein L, Sanguinetti M, Magnani B.
    G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
    [Abstract] [Full Text] [Related]

  • 17. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure?
    Nawarskas JJ, Spinler SA.
    Pharmacotherapy; 1998 Jan; 18(5):1041-52. PubMed ID: 9758314
    [Abstract] [Full Text] [Related]

  • 18. [The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
    Kawahara Y, Hasegawa K, Sawayama T, Inoue S, Nakamura T, Kakumae S, Tadaoka S, Nakao M, Nezuo S.
    Kokyu To Junkan; 1989 Dec; 37(12):1333-40. PubMed ID: 2575781
    [Abstract] [Full Text] [Related]

  • 19. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM, Kramer BL, Topic N.
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
    Volpini M, Gargano M, Cuccia C, Dei Cas L, Gei P, Metra M, Moretti R, Riva S.
    Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.